Melanoma Panel

New York
Approved


Genes

BAP1, BRCA2, CDK4, CDKN2A, MITF, POT1, PTEN, RB1, TP53

Conditions

  • Familial Cutaneous Malignant Melanoma

Clinical Utility

  • Identification of a hereditary susceptibility to malignant melanoma
  • Development of a clinical surveillance plan for early detection
  • Identification of at-risk family members

Lab Method

  • Deletion/Duplication Analysis
  • Next-Gen Sequencing

Test Code

B399

CPT Codes*

81404x1, 81479x1

ABN Required

No

Turnaround Time**

2 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs | Fibroblasts (separate charge for cell culture may apply)

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.